News
04/10/2002
Press Release
Isonics Corporation to Exhibit at SEMICON Europa 2002 Industry Leader to
Introduce New Product Line at Largest International Semiconductor Equipment
and Materials Conference and Exposition
Wednesday April 10, 9:28 am Eastern Time Press Release SOURCE: Isonics Corporation
GOLDEN, Colo.--(BUSINESS WIRE)--April 10, 2002-- Isonics Corporation (Nasdaq:ISON
- news), a leader in the development of isotopically engineered semiconductor
materials and a supplier of isotopes for life sciences and health care applications,
announced that it will be introducing a new line of thick film SOI wafers to
the European community at SEMICON Europa 2002, in Munich, Germany to be held
April 16-18. The Company will be presenting their entire semiconductor materials
product line, including their very popular high thermal conductivity silicon-28
epi wafers. Isonics' SOI wafers are available in 4, 5, and 6-inch diameters
with device layers greater than 1 micron thick. A wide range of custom specifications
is available with 3-4 week delivery times on standard products. Silicon-28 SOI
wafers are also available for customer evaluation. SEMICON Europa, established
to promote international business, learning and networking opportunities for
semiconductor equipment, material and service suppliers, is the largest international
conference and exposition specific to semiconductor equipment and materials
in Europe. The Isonics Corporation is scheduled to be located at booth A4-433.
About Isonics Corporation Isonics is a world leader in isotopically engineered
materials and produces isotopically pure silicon-28 chemicals and wafers for
the semiconductor industry. Isonics also markets and sells stable isotopes for
the health care industry such as carbon-13 for diagnostic breath tests and drug
design, and oxygen-18 for positron emission tomography (PET) imaging. Stable
isotopes can be thought of as ultra pure materials. This high degree of purification
provides enhanced properties as compared to natural materials. Additional information
may be obtained at http://www.isonics.com or http://www.invrel.net. Except for
historical information contained herein, this document contains forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. These statements involve known and unknown risks and uncertainties
that may cause the Company's actual results or outcomes to be materially different
from those anticipated and discussed herein. Further, the Company operates in
industries where securities values may be volatile and may be influenced by
regulatory and other factors beyond the Company's control. Other important factors
that the Company believes might cause such differences are discussed in the
risk factors detailed in the Company's 10-KSB for the year ended April 30, 2001,
and its quarterly report on Form 10-QSB for the nine months ended January 31,
2002, both as filed with the Securities and Exchange Commission, which include
the Company's cash flow difficulties, dependence on significant customers, and
rapid development of technology, among other risks. In assessing forward-looking
statements contained herein, readers are urged to carefully read all cautionary
statements contained in the Company's filings with the Securities and Exchange
Commission. Contact: Isonics Corporation, Golden Stephen J. Burden, 303/279-7900
sburden@isonics.com or Investor Relations Services, Inc., New Smyrna Beach,
FL Nicole Mongelli, 386/409-0200 ison@invrel.net